|
AU588299B2
(en)
*
|
1985-04-08 |
1989-09-14 |
Rafa Laboratories Ltd. |
Artificial microcompartmentalization
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
WO1987000043A1
(en)
*
|
1985-07-05 |
1987-01-15 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
|
FR2628317B1
(fr)
*
|
1988-03-09 |
1991-11-08 |
Lvmh Rech |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
|
|
MX9203504A
(es)
*
|
1988-04-20 |
1992-07-01 |
Liposome Co Inc |
Complejo agente: lipido activo de alta proporcion.
|
|
EP0414806B1
(en)
*
|
1988-05-20 |
1994-07-20 |
The Liposome Company, Inc. |
High ratio active agent:lipid complex
|
|
CA1340241C
(en)
*
|
1988-06-08 |
1998-12-15 |
Fountain Pharmaceuticals, Inc. |
Method for marking solvent dilution microcarriers
|
|
US5269979A
(en)
*
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
|
US4952405A
(en)
*
|
1988-10-20 |
1990-08-28 |
Liposome Technology, Inc. |
Method of treating M. avium infection
|
|
AU4525589A
(en)
*
|
1988-10-27 |
1990-05-14 |
Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
|
DE69032161T2
(de)
*
|
1989-05-25 |
1998-11-19 |
Technology Unlimited Inc |
Abstossmittel für insekten
|
|
ZA911974B
(en)
*
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5264220A
(en)
*
|
1991-11-12 |
1993-11-23 |
Long David M Jr |
Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
|
|
AU3423493A
(en)
*
|
1991-12-31 |
1993-07-28 |
Zymogenetics Inc. |
Methods and compositions for reducing blood loss
|
|
EP0585514B1
(en)
*
|
1992-01-09 |
1998-10-07 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana |
Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin
|
|
US5674855A
(en)
*
|
1992-08-12 |
1997-10-07 |
The Rogosin Institute |
Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
|
|
US5344822A
(en)
*
|
1992-08-12 |
1994-09-06 |
The Rogosin Institute |
Methods useful in endotoxin prophylaxis and therapy
|
|
US5958449A
(en)
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
|
WO1994012155A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Vestar, Inc. |
Antibiotic formulation and process
|
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
|
US5478819A
(en)
*
|
1993-06-23 |
1995-12-26 |
Simo Tarpila |
Phospholipid composition and use thereof
|
|
CA2172245C
(en)
*
|
1993-09-22 |
2003-04-08 |
Jonathan Cohen |
Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein
|
|
EP0664117A1
(de)
*
|
1994-01-25 |
1995-07-26 |
F. Hoffmann-La Roche Ag |
Liposomenlösungen
|
|
US20020028215A1
(en)
|
1999-08-09 |
2002-03-07 |
Jagath L. Kadurugamuwa |
Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
|
|
US6096336A
(en)
*
|
1996-01-30 |
2000-08-01 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
|
EE9800377A
(et)
|
1996-05-08 |
1999-04-15 |
Biogen, Incorporated |
Ret-i ligand (RetL) närvi- ja neerukasvu stimuleerimiseks
|
|
WO1998006435A2
(en)
*
|
1996-08-14 |
1998-02-19 |
Vanderbilt University |
COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA)
|
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
|
US6352996B1
(en)
|
1999-08-03 |
2002-03-05 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
|
WO2003028646A2
(en)
*
|
2001-10-01 |
2003-04-10 |
The Board Of Trustees Of The University Of Illinois |
Methods of treating drug-resistant bacterial infections
|
|
CA2383259A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Celator Technologies Inc. |
Synergistic compositions
|
|
US7850990B2
(en)
*
|
2001-10-03 |
2010-12-14 |
Celator Pharmaceuticals, Inc. |
Compositions for delivery of drug combinations
|
|
US20080075762A1
(en)
*
|
2001-10-03 |
2008-03-27 |
Paul Tardi |
Compositions for delivery of drug combinations
|
|
EP1476194A4
(en)
*
|
2002-02-19 |
2005-05-18 |
Eden Research Plc |
COMPOSITIONS AND METHOD FOR PRESERVING FOODSTUFFS
|
|
WO2003075889A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
DK2363114T3
(da)
*
|
2002-10-29 |
2015-06-22 |
Insmed Inc |
Opretholdt afgivelse af anti-infektionsmidler
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US6846966B2
(en)
*
|
2002-11-26 |
2005-01-25 |
Exxonmobil Chemical Patents Inc. |
Method and apparatus for treating oxygenate-containing feeds and their use in conversion of oxygenates to olefins
|
|
FR2852513A1
(fr)
*
|
2003-03-17 |
2004-09-24 |
Groupe Lepine |
Combinaison d'antibiotiques gentamicine/clindamycine et ses applications aux ciments orthopediques curatifs
|
|
AU2004228631B2
(en)
|
2003-04-02 |
2010-12-02 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
|
|
US20040204435A1
(en)
*
|
2003-04-09 |
2004-10-14 |
Joachim Liehr |
Alternating treatment with topoisomerase I and topoisomerase II inhibitors
|
|
CA2561577A1
(en)
|
2004-03-30 |
2005-10-13 |
Nsgene A/S |
Therapeutic use of a growth factor, nsg33
|
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
|
WO2006032136A1
(en)
*
|
2004-09-20 |
2006-03-30 |
British Columbia Cancer Agency Branch |
Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
|
|
US20110020434A1
(en)
*
|
2005-09-02 |
2011-01-27 |
O'halloran Thomas V |
Nanoparticle arsenic-platinum compositions
|
|
DE102005063375A1
(de)
*
|
2005-09-15 |
2007-04-19 |
Schülke & Mayr GmbH |
Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
|
|
CN101355876B
(zh)
|
2005-11-09 |
2012-09-05 |
康宾纳特克斯公司 |
一种适用于眼部给药的组合物
|
|
PT1962805T
(pt)
|
2005-12-08 |
2016-10-05 |
Insmed Inc |
Composições de anti-infeciosos baseadas em lípidos para tratamento de infeções pulmonares
|
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US8470762B2
(en)
|
2007-05-31 |
2013-06-25 |
Colgate-Palmolive Company |
Fabric softening compositions comprising polymeric materials
|
|
WO2009108407A1
(en)
*
|
2008-02-25 |
2009-09-03 |
The University Of North Carolina At Charlotte Office Of Technology Transfer |
Biodegradable therapeutic nanoparticles containing an antimicrobial agent
|
|
US8039450B2
(en)
|
2008-03-06 |
2011-10-18 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as anti-inflammatory agents
|
|
US20120172429A1
(en)
|
2009-07-10 |
2012-07-05 |
Woolf Clifford J |
Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
|
|
AU2010330747B2
(en)
|
2009-12-18 |
2016-08-11 |
Achelios Therapeutics, Inc. |
Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
|
|
WO2011094450A1
(en)
|
2010-01-27 |
2011-08-04 |
Anacor Pharmaceuticals, Inc |
Boron-containing small molecules
|
|
JP2013532144A
(ja)
|
2010-06-14 |
2013-08-15 |
ハー・ルンドベック・アクチエゼルスカベット |
ＳｏｒＬＡとＧＤＮＦファミリーリガンド受容体の間の相互作用の調節
|
|
ES2606781T3
(es)
*
|
2010-07-23 |
2017-03-27 |
Acea Biotech, Inc. |
Macrólidos polienos antifúngicos y antiparasitarios
|
|
AU2011307488B2
(en)
|
2010-10-01 |
2015-08-20 |
Hoba Therapeutics Aps |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
|
JP6402097B2
(ja)
|
2012-05-21 |
2018-10-10 |
インスメッド インコーポレイテッド |
肺感染症を処置するためのシステム
|
|
MX2015006681A
(es)
|
2012-11-29 |
2016-04-06 |
Insmed Inc |
Formulaciones de vancomicina estabilizadas.
|
|
WO2015175939A1
(en)
|
2014-05-15 |
2015-11-19 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
|
WO2015188140A1
(en)
*
|
2014-06-06 |
2015-12-10 |
The Curators Of The University Of Missouri |
Enhancement of antibiotic efficacy
|
|
EP3226972A4
(en)
|
2014-12-01 |
2018-08-08 |
Achelios Therapeutics, Inc. |
Methods and compositions for treating migraine and conditions associated with pain
|
|
RU2018107695A
(ru)
|
2015-08-03 |
2019-09-05 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Заряженные блокаторы ионных каналов и способы их применения
|
|
JP2019532027A
(ja)
|
2016-08-17 |
2019-11-07 |
ソルスティス バイオロジクス，リミティッド |
ポリヌクレオチド構築物
|
|
WO2019006455A1
(en)
|
2017-06-30 |
2019-01-03 |
Solstice Biologics, Ltd. |
AUXILIARIES OF CHIRAL PHOSPHORAMIDITIS AND METHODS OF USE THEREOF
|
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
|
KR20210145164A
(ko)
|
2019-03-11 |
2021-12-01 |
녹시온 테라퓨틱스 인코포레이티드 |
에스테르 치환된 이온 채널 차단제 및 사용 방법
|
|
AU2020237474A1
(en)
|
2019-03-11 |
2021-09-30 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
SG11202109720WA
(en)
|
2019-03-11 |
2021-10-28 |
Nocion Therapeutics Inc |
Charged ion channel blockers and methods for use
|
|
US10828287B2
(en)
|
2019-03-11 |
2020-11-10 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
WO2021091586A1
(en)
|
2019-11-06 |
2021-05-14 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
US10842798B1
(en)
|
2019-11-06 |
2020-11-24 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
AU2021236130A1
(en)
|
2020-03-11 |
2022-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
CN117940149A
(zh)
|
2021-05-06 |
2024-04-26 |
霍巴治疗公司 |
化疗诱导的神经性疼痛的预防和治疗
|
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|